Liposome-encapsulated daunorubicin for PGP-related multidrug resistance-Reference-Cited by-同舟云学术

Liposome-encapsulated daunorubicin for PGP-related multidrug resistance

Published:1999-07 Issue:1 Volume:106 Page:92-99
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Michieli Mariagrazia,Damiani Daniela,Ermacora Anna,Masolini Paola,Michelutti Angela,Michelutti Teresa,Russo Domenico,Pea Federico,Baccarani Michele

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1999.01505.x/fullpdf

Reference31 articles.

1. Pharmacology of liposomal daunorubicin and its use in Kaposi's sarcoma;Chew;Oncology,1996

2. Mechanisms of drug resistance in hematologic malignancies;Dalton;Seminars in Hematology,1997

3. P-glycoprotein (PGP) and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias;Damiani;Haematologica,1998

4. Expression of multidrug resistance gene (mdr-1) in human normal leukocytes;Damiani;Haematologica,1993

5. P-glycoprotein expression in de novo acute myeloid leukemia;Del Poeta;Leukemia and Lymphoma,1997

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoencapsulation of aptamer-functionalized 5-Fluorouracil liposomes using alginate/chitosan complex as a novel targeting strategy for colon-specific drug delivery;Journal of Drug Delivery Science and Technology;2022-05

2. Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer;Pharmaceutical Research;2018-01-09

3. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia;Annals of Hematology;2014-07-04

4. Targeted Multimodal Liposomes for Nano-delivery and Imaging: An Avenger for Drug Resistance and Cancer;Current Gene Therapy;2013-12-31

5. Amonafide: a future in treatment of resistant and secondary acute myeloid leukemia?;Expert Review of Hematology;2012-02